Interaction of 5-hydroxytryptamine and ketanserin in rat vas deferens subjected to low frequency field stimulation.
スポンサーリンク
概要
- 論文の詳細を見る
The interaction of 5-hydroxytryptamine (5HT) and ketanserin was investigated in isolated rat vas deferens. Ketanserin (10<SUP>-7</SUP> M) almost completely abolished the phasic and the following rhythmic contractions induced by 5HT, whereas the inhibition by prazosin (10<SUP>-6</SUP> M) or methysergide (10<SUP>-6</SUP> M) of 5HT-induced contractions were incomplete. The amplitude of twitch contractions of vas deferens subjected to low frequency (0.1 Hz) field stimulation were substantially unchanged by 5HT (10<SUP>-7</SUP>-10<SUP>-5</SUP> M) per se. After pretreatment of the tissue with ketanserin (10<SUP>-8</SUP>-10<SUP>-6</SUP> M), 5HT, in a concentration-dependent manner, attenuated the amplitude of twitch contractions. Such attenuation of the amplitude was not observed after pretreatments with methysergide (10<SUP>-8</SUP>-10<SUP>-6</SUP> M) or prazosin (10<SUP>-7</SUP>-10<SUP>-5</SUP> M). The 5HT-induced inhibition of twitch contractions in the presence of ketanserin was not antagonized by phentolamine, propranolol, methysergide, morphine, promethazine, cimetidine, atropine or indomethacin. It is suggested that 5HT has dual (excitatory and inhibitory) effects upon nerve transmission of rat vas deferens, and only the excitatory effect is suppressed by ketanserin.
著者
-
Karasawa Akira
Deparment Of Pharmacology Pharmaceutical Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
KUBO Kazuhiro
Department of Cardiovascular Pharmacology, Pharmaceuticals Research Laboratory, Kyowa Hakko Kogyo Co., Ltd.
-
KUBO Kazuhiro
Department of Cardiovascular Pharmacology, Pharmaceuticals Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
-
SHUTO Katsuichi
Department of Cardiovascular Pharmacology, Pharmaceuticals Research Laboratory, Kyowa Hakko Kogyo Co., Ltd.
-
NAKAMIZO Nobuhiro
Department of Cardiovascular Pharmacology, Pharmaceuticals Research Laboratory, Kyowa Hakko Kogyo Co., Ltd.
-
KARASAWA Akira
Department of Cardiovascular Pharmacology, Pharmaceuticals Research Laboratory, Kyowa Hakko Kogyo Co., Ltd.
-
SHUTO Katsuichi
Department of Cardiovascular Pharmacology, Pharmaceuticals Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
-
NAKAMIZO Nobuhiro
Department of Cardiovascular Pharmacology, Pharmaceuticals Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
関連論文
- Excitation and Inhibition via Adenosine Receptors of the Twitch Response to Electrical Stimulation in Isolated Guinea Pig Ileum
- Effects of olopatadine hydrochloride on the release of thromboxane B_2 and histamine from nasal mucosa after antigen-antibody reaction in guinea pigs
- Inhibitory Effect of Olopatadine Hydrochloride on the Sneezing Response Induced by Intranasal Capsaicin Challenge in Guinea Pigs
- Involvement of Neuropeptides in the Allergic Nasal Obstruction in Guinea Pigs
- EXPRESSION OF THE XENOPUS HOMOLOGUES OF HUMAN UBIQUITIN-CONJUGATING ENZYME E2 IN THE OOCYTE MATURSATION PROCESS OF XENOPUS(Developmental Biology,Abstracts of papers presented at the 74^ Annual Meeting of the Zoological Society of Japan)
- Effects of KW-5617 (Zaldaride Maleate), a Potent and Selective Calmodulin Inhibitor, on Secretory Diarrhea and on Gastrointestinal Propulsion in Rats
- Effect of KW-5092, Novel Gastroprokinetic Agent, on the Peristalsis in the Isolated Guinea Pig Ileum
- Effects of KW-3902 (8-(Noradamantan-3-yl)-1,3-dipropylxanthine), an Adenosine A_1-Receptor Antagonist, on Urinary Excretions of Various Electrolytes in Rats
- Antihypertinsive Effects of KW - 3902, an Adenosine A_1 - Receptor Antagonist, in Dahl Salt-Sensitive Rats
- Effects of KW-3902, an Adenosine A_1 - Receptor Antagonist, on Ascites Volume in Puromycin Aminonucleoside (PAN) - Induced Nephrotic Rats
- Effects of the Adenosine A_1 - Receptor Antagonist on Defecation, Small Intestinal Propulsion and Gastric Emptying in Rats
- Protective Effects of KW-3902, an Adenosine A_1-Receptor Antagonist, against Cisplatin-Induced Acute Renal Failure in Rats
- Protective Effects of Benidipine Hydrochloride (KW-3049), a Calcium Antagonist, against Experimental Arterial Calcinosis and Endothelial Dysfunction in Rats
- Early Thrombolysis by Recombinant Tissue-Plasminogen Activator Is Beneficial to the Ischemic Myocardium
- PURIFICATION OF HISTAMINE RECEPTOR (V) —ASSESSMENT OF THE DOUBLE LABELING METHOD—
- EFFECTS OF NONSPECIFIC SMOOTH MUSCLE RELAXANTS ON GLYCOGEN PHOSPHORYLASE ACTIVITY IN DEPOLARIZED TAENIA CAECUM OF GUINEA PIG
- Antithrombotic Effects of KW-3635, a Thromboxane A2-Receptor Antagonist, in Guinea Pigs
- Protective Effect of Benidipine against the Development of Glomerular Sclerosis in Experimental Nephrotic Syndrome
- Protective Effects of Benidipine on Arachidonic Acid-Induced Acute Cerebral Ischemia in Rats
- BUTANOL EXTRACTS FROM MYELIN FRAGMENTS-V. 5-HYDROXYTRYPTAMINE BINDING TO THE MITOCHONDRIAL BUTANOL EXTRACTS AND THE INTER-RELATIONSHIP WITH MYELIN BUTANOL EXTRACTS
- Stimulating Effects of KW-5092, a Novel Gastroprokinetic Agent, on the Gastric Emptying, Small Intestinal Propulsion and Colonic Propulsion in Rats
- KW - 5092, a Novel Gastroprokinetic Agent, Reverses the Norepinephrine - Induced Decline of the Gastric Mucosal Blood Flow in Rats
- Protective Effect of KW-3635, a Specific Thromboxane A2-Receptor Antagonist, on Experimental Glomerulonephritis in Mice
- Interaction of 5-hydroxytryptamine and ketanserin in rat vas deferens subjected to low frequency field stimulation.
- Inhibitory Effects of KW-3902, a Selective Adenosine A1-Receptor Antagonist, on the Adenosine-Induced Shortening of Action Potential Duration in Guinea Pig Atrial Muscles.
- Protective Effects of KW-3902, an Adenosine A1-Receptor Antagonist, Against the Nephropathy Induced by Repeated Administration of Cisplatin in Rats.
- Enhancement by KW-5092, a Novel Gastroprokinetic Agent, of the Release of Acetylcholine from Enteric Neurons in the Guinea Pig Ileum.
- Protective Effect of Cisapride against Indomethacin-Induced Obstruction of the Gastric Mucosal Hemodynamics in Rats.
- Effects of KW-3902, a Novel Adenosine A1-Receptor Antagonist, on Cephaloridine-Induced Acute Renal Failure in Rats.
- Inhibition of thromboxane A2-induced vasocontraction by KF4939, a new anti-platelet agent, in rabbit mesenteric and dog coronary arteries.
- Protective Effects of KW-3635, a Thromboxane A2 Antagonist, on Arachidonic Acid-Induced Transient Cerebral Ischemia in Dogs.
- Enhancement by KW-5092, a Novel Gastroprokinetic Agent, of the Gastrointestinal Motor Activity in Dogs.
- Diuretic Effects of KW-3902, a Novel Adenosine A1-Receptor Antagonist, in Various Models of Acute Renal Failure in Rats.
- Pharmacological Properties of KF18259, a Novel 5-HT3-Receptor Antagonist, in Rats: Inhibition of the Distal Colonic Function.
- Effects of KW-5092, a Novel Gastroprokinetic Agent, on the Delayed Colonic Propulsion in Rats.
- Colonic Giant Migrating Contractions Induced by Glycerol Enema in Anesthetized Rats.
- Effects of Benidipine on Renal Function in Anesthetized Spontaneously Hypertensive Rats.
- Protective Effects of KW-3902, an Adenosine A1-Receptor Antagonist, Against Cisplatin-Induced Apoptosis in Rat Kidney.
- Effects of Repeated Administration of KW-3902, a Novel Adenosine A1-Receptor Antagonist, on Its Pharmacological Actions.
- Protective Effects of KW-3902, a Novel Adenosine Al-Receptor Antagonist, against Gentamicin-Induced Acute Renal Failure in Rats.
- Inhibitory Effect of KW-3635, a New Thromboxane A2-Receptor Antagonist, on Arterial Thrombosis in Guinea Pigs.
- Renal tubular site of action of KW-3902, a novel adenosine A1-receptor antagonist, in anesthetized rats.